Berlin-Buch. The health location.
For one hundred years, physicians and researchers collaborating at Berlin-Buch have been devoted to advancing health.
Here you are invited to learn about Berlin-Buch and its partners and to become acquainted with the unique atmosphere of the campus where the medicine of the future is being created.
Berlin-Buch – dedicated to health
Outstanding hospitals and excellent achievements in basic biomedical research have long been hallmarks of Berlin-Buch. The internationally renowned location for science and health care provision is one of the major players in the health industry cluster in the capital city region.
In line with its clear focus on biomedicine, the Berlin-Buch location offers life science companies and research institutions unique conditions for synergies and for value creation networks. Here clinicians and basic researchers collaborate in joint projects to apply new insights gained in the high-tech laboratories to patient care. New discoveries are available to patients at Berlin-Buch already in the stage of clinical trials.
The promotion and preservation of health is the overarching goal of the circa 6500 people who work at Berlin-Buch – among them scientists of world renown, highly motivated physicians, teachers in the health professions and innovative entrepreneurs.
News Buch Berlin
Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...
more ...Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...
more ...OMEICOS Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
Interim data confirms OMT-28's strong safety profile in PMD patients, top-line data expected mid-2025
more ...Events Buch Berlin
05.11.2024, 16:00
Die Zukunft der Hirnkrebstherapie: Fortschritte, Herausforderungen und Visionen
Vortrag in der Reihe: Neue Wege in der Biomedizin - Aktuelle Forschungsthemen des Campus Berlin-Buch
more ...06.11.2024, 13:30
Einladung zur Vorlesung: "Rätselhafte Gehirne - Ursachen von Demenz bei Jung und Alt"
in der Reihe "Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch"
more ...11.11.2024, 09:00
Fachkraft für Molekularbiologie
Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung.
more ...